Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine

Bacillus Calmette-Guerin (BCG) is the only licensed vaccine to prevent children from tuberculosis (TB), whereas it cannot provide effective protection for adults. Our previous work showed a novel vaccine candidate, liposomal adjuvant DMT emulsified with a multistage antigen CMFO, could protect mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Ling, Wu, Yaqi, Zhang, Yandi, Zhou, Zijie, Lei, Qing, Ullah, Nadeem, Banga Ndzouboukou, Jo-Lewis, Lin, Xiaosong, Fan, Xionglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561437/
https://www.ncbi.nlm.nih.gov/pubmed/33117374
http://dx.doi.org/10.3389/fimmu.2020.575504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561437/
https://www.ncbi.nlm.nih.gov/pubmed/33117374
http://dx.doi.org/10.3389/fimmu.2020.575504

Ejemplares similares